Our results provide a framework for understandingthe processes leading to tau aggregation in disease and for selectingpossible tau forms as targets in the development of therapeutic interventionsin Alzheimer’s disease. Here, MAPT is linked to early-onset autosomal dominant Alzheimer disease.